Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Takahiro Iizuka & Mitsuhiro Matsukawa. (2008) Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients. Climacteric 11:4, pages 287-295.
Read now
Read now
Articles from other publishers (15)
Matthias Göllner, Stefan Holst, Matthias Fenner & Johannes Schmitt. (2010) Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: A clinical report. The Journal of Prosthetic Dentistry 103:4, pages 196-201.
Crossref
Crossref
E. Michael Lewiecki, Ann M. Babbitt, Veronica K. Piziak, Zafer E. Ozturk & Henry G. Bone. (2008) Adherence to and Gastrointestinal Tolerability of Monthly Oral or Quarterly Intravenous Ibandronate Therapy in Women with Previous Intolerance to Oral Bisphosphonates: A 12-Month, Open-Label, Prospective Evaluation. Clinical Therapeutics 30:4, pages 605-621.
Crossref
Crossref
PAUL D. MILLER. 2008. Osteoporosis. Osteoporosis
1725
1742
.
Yusuf Farouk Suleman, Shabnum Meer & Russel Lurie. (2007) Bisphosphonate-induced Osteonecrosis of the Jaws: Review, Clinical Implications and Case Report. Head and Neck Pathology 1:2, pages 156-164.
Crossref
Crossref
Hongjun Peng, Yasuyoshi Sohara, Rex A. Moats, Marvin D. NelsonJr.Jr., Susan G. Groshen, Wei Ye, C. Patrick Reynolds & Yves A. DeClerck. (2007) The Activity of Zoledronic Acid on Neuroblastoma Bone Metastasis Involves Inhibition of Osteoclasts and Tumor Cell Survival and Proliferation. Cancer Research 67:19, pages 9346-9355.
Crossref
Crossref
E Michael Lewiecki. (2006) Prevention of osteoporotic fractures. Aging Health 2:4, pages 649-659.
Crossref
Crossref
Paul D. Miller. 2006. Osteoporosis and the Osteoporosis of Rheumatic Diseases. Osteoporosis and the Osteoporosis of Rheumatic Diseases
192
202
.
Zübeyde Nur Özkurt, Sefa Güliter, Işık Keleş & Hatice Keleş. (2005) Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis. Clinical Rheumatology 24:6, pages 665-666.
Crossref
Crossref
J. D. Ringe, A. Dorst & H. Faber. (2005) Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporosis International 16:12, pages 2063-2068.
Crossref
Crossref
Michael J. Grecula & Mabel E. Caban. (2005) Common Orthopaedic Problems in the Elderly Patient. Journal of the American College of Surgeons 200:5, pages 774-783.
Crossref
Crossref
Daisuke Togawa, Isador H. Lieberman, Thomas W. Bauer, Mary Kay Reinhardt & Mark M. Kayanja. (2005) Histological Evaluation of Biopsies Obtained From Vertebral Compression Fractures: Unsuspected Myeloma and Osteomalacia. Spine 30:7, pages 781-786.
Crossref
Crossref
Paul D. Miller. (2005) Treatment of osteoporosis in chronic kidney disease and end-stage renal disease. Current Osteoporosis Reports 3:1, pages 5-12.
Crossref
Crossref
Paul D. Miller. (2005) Treatment of metabolic bone disease in patients with chronic renal disease: A perspective for rheumatologists. Current Rheumatology Reports 7:1, pages 53-60.
Crossref
Crossref
Gordon J Strewler. (2005) Long-term bisphosphonates for osteoporosis: An introduction. BoneKEy-Osteovision 2:1, pages 6-9.
Crossref
Crossref
Feng Cheng & Eric Oldfield. (2004) Inhibition of Isoprene Biosynthesis Pathway Enzymes by Phosphonates, Bisphosphonates, and Diphosphates. Journal of Medicinal Chemistry 47:21, pages 5149-5158.
Crossref
Crossref